Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
Blood|June 15, 1997
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapyS Giralt, E Estey, M Albitar, et al.Bone Marrow Transplantation|March 30, 2004
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphomaU Popat, C Hosing, R M Saliba, et al.Bone Marrow Transplantation|January 27, 2015
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allograftsG S Hobbs, A Hamdi, P D Hilden, et al.Bone Marrow Transplantation|August 12, 2009
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCTS O Ciurea, R Saliba, G Rondon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcomeU Popat, D Przepiork, R Champlin, et al.Blood|February 7, 2001
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationS Giralt, P F Thall, I Khouri, et al.Bone Marrow Transplantation|April 5, 2005
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimenP Anderlini, R Saliba, S Acholonu, et al.Leukemia|August 31, 2007
Genetically identical twin transplantation for chronic lymphocytic leukemiaS Z Pavletic, G Zhou, K Sobocinski, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1D Przepiorka, R Saliba, K Cleary, et al.Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Breast CancerR W Carlson, B O Anderson, W Bensinger, et al.Pageof 21